Followers | 723 |
Posts | 61829 |
Boards Moderated | 0 |
Alias Born | 05/15/2006 |
Monday, October 02, 2017 12:03:15 AM
I went to EDGAR and opened up the link to the Letter of intent in the 8-k about NSEH buying out that company, so I could read it. This must be the 300nth time he is spinning a buyout lie.
Yates said he is going to pay the $2.5 million for it in NSEH shares, common stock. No mention that the shares are worthless, and NSEH is bankrupt.
NSEH said they have a hair less than 3 billion shares a few days ago. They really have more.
They are going to pay for the $2.5 million with NSEH shares, common stock, worth .0001 per share. That is 25 billion shares. Add that to the 3 billion they say they have, the AS goes to 28 billion shares.
Here is how stupid Yates is: If Yates gives them 25 billion shares, they own NSEH and hold the controlling interest.
This is the sentence in the deal which I could open in EDGAR. If you want to see the whole thing, go there.
The exercise price of the option is $2,500,000 in $0.0001 par value restricted common stock (the “Purchase Price”) in exchange for 100% of the outstanding equity of the Company. The Purchase Price is to be paid as follows: (i) $2,500,000 in $0.0001 par value restricted common stock
Recent VISM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 09:16:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 09:20:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 01:28:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:41:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 08:33:23 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM